Shares of ResMed Inc. RMD shed 4.58% to $225.79 Tuesday, on what proved to be an all-around rough trading session for the ...

Resmed has pioneered innovations in respiratory therapy, including CPAP therapy and digital health solutions. The company’s last major brand update in 2014 marked its shift to connectivity, ...

Resmed (RMD) announced a comprehensive brand evolution designed to unify its brand portfolio to serve more people and healthcare providers ...

ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.

Resmed (NYSE: RMD) announced today that it began a comprehensive brand evolution to unify its brand portfolio.

ResMed showed 29% EPS growth last quarter. Sales gains came in at 10%. ResMed earns the No. 6 rank among its peers in the Medical-Products industry group. Boston Scientific, Penum ...

Down, but certainly not out. The post Should you buy this top ASX share in the dip? appeared first on The Motley Fool ...

Shares of ResMed Inc. RMD advanced 3.29% to $232.44 Friday, on what proved to be an all-around positive trading session for ...

StockNews.com cut shares of ResMed (NYSE:RMD – Free Report) from a buy rating to a hold rating in a research note published on Friday morning. Several other equities analysts have also issued reports ...

Shares of ResMed Inc. (NYSE:RMD – Get Free Report) have earned a consensus rating of “Moderate Buy” from the fifteen research ...

Brand Evolution Unites Brands Under One Resmed Identity to Make Better Sleep and Breathing Health More Accessible to EveryoneSAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), ...